title: Influenza Vaccination of Patients Receiving Statins: Where Do We Go From Here?
authors.affiliation: Department of Medicine Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.
authors.forename: Robert L
authors.initials: RL
authors.lastname: Atmar
authors.affiliation: Department of Medicine Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.
authors.forename: Wendy A
authors.initials: WA
authors.lastname: Keitel
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D007252:Influenza Vaccines / Q000276:immunology*; D007251:Influenza, Human / Q000517:prevention & control*; D008297:Male; D012141:Respiratory Tract Infections / Q000276:immunology*
chemical_list: D000893:Anti-Inflammatory Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007252:Influenza Vaccines
keywords: immunogenicity; influenza; influenza vaccines; statins; vaccine effectiveness